Study S000062

Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04185350
Study type: INTERVENTIONAL
Phase: EARLY_PHASE1
Masking: NONE
Status: UNKNOWN
Enrollment: 60
Start: 2019-05-05
Primary completion: 2020-04-05
Lead sponsor: Nanjing First Hospital, Nanjing Medical University
Conditions: Insulinoma
Interventions: DRUG:68Ga-NOTA-MAL-Cys39-exendin-4
Results posted: FALSE

Registered primary outcomes

Standardized uptake value [1 year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.